Previous 10 | Next 10 |
home / stock / nicxf / nicxf news
Nicox SA ( OTCPK:NICXF ) has initiated the first Phase 3 clinical trial, named Mont Blanc, evaluating NCX 470 for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension, by enrolling the first 12 patients. More news on: Nicox S.A., Healthca...
Nicox SA ( OTCPK:NICXF ) has held a Type C meeting with the FDA , wherein data from Danube Phase 2 clinical trial of NCX 4251 was reviewed and the next NCX 4251 trial designs were discussed. More news on: Nicox S.A., Healthcare stocks news, Read more ...
Nicox SA ( OTCPK:NICXF ) has amended its December 2018 license agreement with Ocumension under which the latter secured exclusive development and commercialization rights to NCX 470 for glaucoma in China. More news on: Nicox S.A., Healthcare stocks news, Read more ...
Nicox SA ( OTCPK:NICXF ) announces that exclusive licensee Bausch + Lomb's (NYSE: BHC ) Vyzulta (latanoprostene bunod ophthalmic solution), 0.024% has been approved in Hong Kong and Argentina for the reduction of intraocular pressure in patients with open-angle glaucoma or o...
Deals and Financings Jibeier Pharma, headquartered in Zhenjiang, Jiangsu Province, reported that its filing to IPO on the new Science and Technology Innovation Board ((STAR)) has been accepted for review by the Shanghai Stock Exchange. The company expects to raise $100 million in the offer...
The following slide deck was published by Nicox S.A. in conjunction with this Read more ...
Nicox ( OTCPK:NICXF ): FY net loss of €18.4M More news on: NICOX SA EUR ORD NEW, Earnings news and commentary, Healthcare stocks news, , Read more ...
Nicox ( OTCPK:NICXF ): Q4 Revenue of €3.3M More news on: NICOX SA EUR ORD NEW, Earnings news and commentary, Healthcare stocks news, , Read more ...
Nicox SA ( OTCPK:NICXF ) and Ocumension Therapeutics have entered into an exclusive license agreement for the development and commercialization of Nicox's, NCX 470, targeting patients with glaucoma or ocular hypertension for a territory comprising mainland China, Hong Kong, Macau and Taiwa...
Nicox ( OTCPK:NICXF ): Q3 Revenue of $0.44M More news on: NICOX SA EUR ORD NEW, Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Nicox SA Company Name:
NICXF Stock Symbol:
OTCMKTS Market:
Attachment EN_DenaliLastUSPatient_PR_FINAL
Attachment EN_Nicox Conferences 2024_FINAL
1 Net revenue consists of revenue from collaborations less royalty payments 2 Intra-ocular pressure Attachment EN_Q22024Results_PR_FINAL